Ryan P Cantwell Chater

6PUBLICATIONS
20CO-AUTHORS
GlycoconjugatesProteins and peptidesNeurology and neuromuscular diseasesEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 15, 2026
Identification of Non-competitive and Reversible Inhibitors of Glycine Transporter 2: A Promising Non-opioid Therapeutic Strategy for Neuropathic Pain.

|Feb 16, 2026
A reversible allosteric inhibitor of GlyT2 for neuropathic pain without on-target side effects.

Ryan P Cantwell Chater, Julian Peiser-Oliver, Tanmay K Pati

|Dec 03, 2025
A reversible allosteric inhibitor of GlyT2 alleviates neuropathic pain without on-target side effects.

Ryan P Cantwell Chater, Julian Peiser-Oliver, Tanmay K Pati

|Aug 28, 2025
Current Nonopioid Small Molecule Approaches Toward the Treatment of Neuropathic Pain.

Christopher L Cioffi, Irina Lotsaris, Ryan P Cantwell Chater

|Dec 22, 2023
The efficacy of the analgesic GlyT2 inhibitor, ORG25543, is determined by two connected allosteric sites.

Ryan Cantwell Chater, Ada S Quinn, Katie Wilson

|Jan 23, 2023
Membrane cholesterol regulates inhibition and substrate transport by the glycine transporter, GlyT2.

Zachary J Frangos, Katie A Wilson, Heather M Aitken

Pageof 1

Frequent Collaborators

5 joint publications

Robert J Vandenberg

4 joint publications

Christopher L Cioffi

4 joint publications

Irina Lotsaris

3 joint publications

Megan L O'Mara